Skip to content

ADVIA® Chemistry µALB Microalbumin Reagents 10318197Recalls & reported problems

Siemens Healthcare Diagnostics Inc. · Microalbumin - ADVIA Chem. - RGT - 4x105/4x130 tests · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00630414517643), received between Jan 13, 2023 and Jan 13, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Low Test Results” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Aug 15, 2024Class IIOpen, Classified

    Atellica CH Microalbumin_2 (ALB_2) and the ADVIA Chemistry Microalbumin_2 (ALB_2) are not meeting the High-Dose Hook Effect claim/Prozone Effect claim as stated in the Instructions for Use (IFU) on the Atellica CH, Atellica CI Analyzers, ADVIA 1800 Chemistry Systems, ADVIA 2400 Chemistry Systems, and ADVIA Chemistry XPT Systems, may result in erroneously depressed microalbumin patient results.

    Z-3170-2024 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗

Most reported problems

Device problems

  • Low Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 13, 2023Low Test Results; Low Test Results

    FALSELY DEPRESSED MICROALBUMIN_2 (ALB_2) RESULTS WERE OBTAINED ON 2 PATIENT SAMPLES ON AN ATELLICA CH 930 ANALYZER, SERIAL NUMBER (S/N): (B)(4), USING ADVIA CHEMISTRY MICROALBUMIN REAGENT. THE DISCORDANT RESULTS WERE REPORTED TO THE PHYSICIAN(S). THE SAMPLES WERE REPEATED ON THE SAME ANALYZER THE FOLLOWING DAY. THE REPEAT RESULTS WERE HIGHER THAN THE DISCORDANT RESULTS. THE REPEAT RESULTS WERE REPORTED, AS THE CORRECT RESULTS, TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSELY DEPRESSED ALB_2 RESULTS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16158731 ↗

Other INDICATOR METHOD, PROTEIN OR ALBUMIN (URINARY, NON-QUANT.) devices

All INDICATOR METHOD, PROTEIN OR ALBUMIN (URINARY, NON-QUANT.) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page